American cutaneous leishmaniasis: use of a skin test as a predictor of relapse after treatment

• Үндсэн зохиолчид: Valéria M.A. Passos (Зохиогч), Sandhi M. Barreto (Зохиогч), Alvaro J. Romanha (Зохиогч), Antoniana U. Krettli (Зохиогч), Ângela C. Volpini (Зохиогч), Maria Fernanda F. Lima e Costa (Зохиогч)
• Формат: Ном
• Хэвлэсэн: The World Health Organization, 2000-08-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

While relapses following clinical cure of American cutaneous leishmaniasis are frequent, no test has been described until now to predict such relapses. A cohort of 318 American cutaneous leishmaniasis patients was followed up for two years after treatment with meglumine antimoniate, during which tim...